Publications by authors named "Fenge Yang"

Claim this Profile
T
The efficacy, safety, and pharmacokinetics of N8-GP in previously treated Chinese patients with haemophilia A: results from the phase 3b pathfinder10 study.
Runhui Wu, Yun Chen, Wenqian Li, Jing Sun, Feng'e Yang, Renchi Yang

Blood Coagul Fibrinolysis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of an innovative approach to estimating FVIII levels and designing personalised doses in the prophylactic treatment of haemophilia A: based on the principle of the two-compartment model.
Zipeng Wei, Jianxing Zhou, Baohua Xu, You Zheng, Qingxia Liu, Fenge Yang

BMJ Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical composition of the traditional Chinese medicine compound (ICAM), its antifungal effects against Candida albicans, and the underlying Mechanisms: Therapeutic potential and safety evaluation for vulvovaginal candidiasis.
Shuang Zhu, Jianfang Sun, Xueling Bi, Ziyi Wang, Fenge Yang

J Ethnopharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of a new 10% intravenous immunoglobulin (IVIG) in Chinese patients with primary immune thrombocytopenia (ITP): a multicenter, single-arm, phase III trial.
Huacong Cai, Jishi Wang, Zhenyu Yan, Hu Zhou, Zhenyu Li, Feng'e Yang

Clin Exp Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impacts of the COVID-19 pandemic on pediatric and adult patients with hemophilia.
Shuxia Zhang, Bangxiang Xie, Yanfang Lin, Chunrong Chen, Shu Yang, Feng'e Yang

Ann Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study.
Yu Hu, Xiaofan Liu, Hu Zhou, Shujie Wang, Ruibin Huang, Feng'e Yang, Linhua Yang, Renchi Yang

Lancet Haematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety and pharmacokinetics of recombinant human coagulation factor VIII (omfiloctocog alfa) in previously treated Chinese children with severe hemophilia A.
Runhui Wu, Xiaoling Wang, Xielan Zhao, Yanli Cheng, Zeping Zhou, Fenge Yang, Renchi Yang

Haemophilia· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal gammopathy of undetermined significance (MGUS) characterized by refractory lower gastrointestinal postoperative bleeding with coagulopathy.
Shuxia Zhang, Zhifen Chen, Meijuan Huang, Rong Zhan, Long Wu, Feng'e Yang

Intractable Rare Dis Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic, efficacy and safety evaluation of B-domain-deleted recombinant FVIII (SCT800) for prophylactic treatment in adolescent and adult patients with severe haemophilia A.
Feng Xue, Xielan Zhao, Jing Sun, Xiaojing Zeng, Fenge Yang, Renchi Yang

Haemophilia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A.
Yongqiang Zhao, Yu Hu, Jie Jin, Xielan Zhao, Xuefeng Wang, Renchi Yang, Feng'e Yang

Clin Appl Thromb Hemost· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Turoctocog Alfa in the Prevention and Treatment of Bleeding Episodes in Previously Treated Patients from China with Severe Hemophilia A: Results from the Guardian 7 Trial.
Runhui Wu, Jing Sun, Weiqun Xu, Qun Hu, Wenqian Li, Feng'e Yang, Renchi Yang

Ther Clin Risk Manag· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese guidelines for treatment of adult primary immune thrombocytopenia.
Xin-Guang Liu, Xiao-Chuan Bai, Fang-Ping Chen, Yun-Feng Cheng, Ke-Sheng Dai, Feng-E Yang, Lin-Hua Yang, Ren-Chi Yang, Tong-Hua Yang

Int J Hematol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Expression of Hydrodynamic Injection-mediated PD-L1 in Myeloablative Conditioning Mouse Model].
Xiao-Fan Li, Nai-Nong Li, Feng-E Yang, Yuan-Zhong Chen

Zhongguo Shi Yan Xue Ye Xue Za Zhi· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Total knee arthroplasty for the treatment of hemophilic arthropathy of the knee].
Fen-Yong Chen, Feng-E Yang, Qi Chen

Zhongguo Gu Shang· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis